Vivoryon Therapeutics AG   Report issue

For profit Phase 2
Founded: Halle Germany (1997)

Organization Overview

First Clinical Trial
2020
NCT04498650
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Vivoryon Therapeutics AG | Vivoryon Therapeutics N.V.